Experienced workforce and regulatory track record in place

We have an experienced workforce and capabilities across our network to help you meet regulatory as well as Environment, Health and Safety (EHS) requirements for your next project. Our development and manufacturing site network is routinely inspected by global regulatory authorities including US FDA, EMA, MHRA & Swissmedic. Our cross-intercontinental sites in Visp (CH) and Nansha (CN) are approved for production of API and HPAPI for multiple markets.

containment and safety
Work with one partner with broad capabilities and integrated approach

Our broad capabilities and integrated approach enables you to use one partner throughout your project, from development through to manufacturing. This reduces risk, complexity and time to bring your HPAPI product to market. Our dedicated program management and experienced teams work together with you to ensure swift and efficient technology transfer and scale-up as required.

Very approachable, flexible and always informed about the status of ongoing activities to support the project. The Program Manager was also great at coordinating activities across multiple sites.

-Small Biotech, based in Europe

Advanced technology and innovation are the core to our HPAPI approach

Advanced technology and innovation are core to our HPAPI approach, and investments remain core to our business. For example, we have developed and used continuous manufacturing to optimize production efficiency. This approach to innovation extends to our business models, which are highly flexible and designed to meet our customers’ specific requirements. Dedicated setups for HPAPI are just one example of how we can provide security of supply.

Nansha - Leading HPAPI Innovations

Meet Christian Noti, Ph.D.

Team Leader for API Development Services

Visp, Switzerland

Christian Noti serves as a Team Leader for API Development Services and the Highly Potent API (HPAPI) Laboratory at Lonza’s site in Visp, Switzerland. He joined Lonza as a Research Chemist in 2008, responsible for the development and technology transfer of highly complex, chemically challenging multistep processes to produce APIs. In the past 7 years, he has played a significant role in further expanding Lonza’s HPAPI business in the Highly Potent Products Development and Lab Scale Manufacturing team.

Our locations
Global, high-quality facilities that bring your molecule to life

Sign up. Stay up-to-date.

Join our community to receive tailored insights and resources

By clicking "Submit" you agree to our Legal Disclaimer terms and conditions and the Lonza Privacy and Cookies Policy.